LONDON – It was a love-in to celebrate the 20th anniversary of the EMA and the start of centralized approvals across Europe, but Elias Zerhouni, president of global R&D at Sanofi SA, pulled few punches in his keynote address, calling for greater consistency, increased speed and a more science-based approach to regulation.